By reducing the harmful effects of angiotensin II, RAAS blockade with an ACE inhibitor might provide a rational approach to reverse early hypertension-induced vascular damage and cognitive alterations.[3,22] In this follow-up study, we investigated the effects of three months of ACE inhibition on hypertension-induced initial vascular and cognitive changes. The gene discussed is ACE; the disease is hypertensive disorder.